Cardiovascular risk in the syndrome of apnea-hipopnea of the dream;Riesgo cardiovascular en el síndrome de apnea-hipopnea del sueño

Archivos de Bronconeumologia

Volumn 41, Issue SUPPL. 5, 2005, Pages 30-35

  Parra Ordaz, O ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APNEA HYPOPNEA INDEX; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG FUNCTION TEST; MORTALITY; POSITIVE END EXPIRATORY PRESSURE; PULMONARY HYPERTENSION; REVIEW; RISK ASSESSMENT; SLEEP APNEA SYNDROME; SYMPTOMATOLOGY;

EID: 34547758836     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/s0300-2896(05)70765-1     Document Type: Review

References (65)

1. Sullivan CE, Issa FG, Berthon Jones M, Eyes L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1:862-5.
2. Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001;163:685-9.
3. Solans M, Montserrat JM, Vila X, Pera G, Bolívar I, Bardagí S. Prevalence of sleep apnea hypopnea by means of a home study and related clinical feature. Am J Respir Crit Care Med. 2001;163: A385.
4. He J, Kryger MH, Zorick FJ. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest. 1988;94:9-14.
5. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Chest. 1988;94:1200-4.
6. Lavie P, Herer P, Peled R, et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep. 1995;18:149-57.
7. Martí S, Sampol G, Muñoz X, Torres F, Roca A, Lloberes P, et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J. 2002;20:1511-8.
8. Marín JM, Carrizo SJ, Vicente F, Agustí A. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-53.
9. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA. 2000;283:1829-36.
10. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-84.
11. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ. 2000;320:479-82.
12. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000;160:2289-95.
13. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19-25.
14. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest. 1997;99:106-9.
15. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension. 2000;35:144-7.
16. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med. 2001;163:344-8.
17. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003;107:68-73.
18. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002;359:204-10.
19. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-46.
20. Chobanian AV, Bakris GL, Black HR, et al, National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
21. Good DC, Henkle JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke. 1996;27:252-9.
22. Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke. 1996;27:401-7.
23. Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep. 1999;22:217-23.
24. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men, I: prevalence and severity. Am J Respir Crit Care Med. 1998;157:144-8.
25. Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med. 2000;161:375-80.
26. Spriggs DA, French JM, Murdy JM, Curless RH, Bates D, James OF. Snoring increases the risk of stroke and adversely affects prognosis. Q J Med. 1992;83:555-62.
27. Iranzo A, Santamaría J, Berenguer J, Sánchez M, Chamorro A. Prevalence and clinical importance of sleep apnea in the first night after cerebralnfarction. Neurology. 2002;58:911-6.
28. Parra O, Arboix A, Montserrat JM, Quintó L, Bechich S, García-Eroles L. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J. 2004;24:1-6.
29. Parra O. Sleep-disordered breathing and stroke: is there a rationale for treatment? Eur Respir J. 2001;18:619-22.
30. Wessendorf TE, Wang YM, Thilmann AF, Sorgenfrei U, Konietzko N, Teschler H. Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke. Eur Respir J. 2001;18:623-9.
31. Sandberg O, Franklin KA, Bucht G, Eriksson S, Gustafson Y. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J. 2001;18:630-4.
32. Hui D, Choy D, Wong L, Ko F, Li T, Woo J, et al. Prevalence of sleep-disordered breathing and continuous positive airway pressure complience. Chest. 2002;122:852-60.
33. Parra O. Trastornos respiratorios del sueño y enfermedad cerebrovascular. Arch Bronconeumol. 2004;40:34-8.
34. Shepard JWJr, Pevernagie DA, Stanson AW, Daniels BK, Sheedy PF. Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 1996;153:250-4.
35. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens. 1990;8:941-6.
36. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation. 1998;97: 2154-9.
37. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999;160:1101-6.
38. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348:1233-41.
39. Naughton MT, Bradley TD. Sleep apnea in congestive heart failure. Clin Chest Med. 1998;19:99-113.
40. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation. 2000;102:61-6.
41. Davies RJO, Harrington KJ, Omerod JM. Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered bresthing. Am Rev Respir Dis. 1993;147:630-4.
42. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet. 1990;336:261-4.
43. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med. 2000;162:81-6.
44. Mooe T, Franklin KA, Wiklund U, Rabben T, Holmstrom K. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest. 2000;117:1597-602.
45. Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnoea and nocturnal angina. Lancet. 1995;45:1085-7.
46. Gami AS, Svatikova A, Wolk R, Olson EJ, Duenwald CJ, Jaffe AS, et al. Cardiac troponin T in obstructive sleep apnea. Chest. 2004;125:2097-100.
47. Koehler U, Becker HF, Grimm W, Heitmann J, Peter JH, Schafer H. Relations among hypoxemia, sleep stage, and bradyarrhythmia during obstructive sleep apnea. Am Heart J. 2000;139:142-8.
48. Grimm W, Koehler U, Fus E, et al. Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. Am J Cardiol. 2000;86:688-92.
49. Gami AS, Pressman G, Caples SM, Kanagla R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110:364-7.
50. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med. 2001;164:1910-3.
51. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589-94.
52. Porthan KM, Melin JH, Kupila JT, Venho KK, Partinen MM. Prevalence of sleep apnea syndrome in lone atrial fibrillation: a case-control study. Chest. 2004;125:879-85.
53. Alchanatis M, Tourkohoriti G, Kakouros S, Kosmas E, Podaras S, Jordanoglou JB. Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration. 2001;68:566-72.
54. Sajkov D, Wang T, Saunders NA, Bune AJ, Neill AM, Mcevoy RD. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999;159:1518-26.
55. Gami AS, Sommers VK. Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur Heart J. 2004;25:709-11.
56. Hedner J. Regulation of systemic vasculature in obstructive sleep apnea syndrome. Sleep. 2000;23:132-4.
57. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-904.
58. Chin K, Ohi M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1996;153:1972-6.
59. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest. 1995;108:625-30.
60. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effect of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17:61-6.
61. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, et al. Circulating nitric oxid is supressed in obstructive sleep apnea and is reversed by NCPAP. Am J Respir Crit Care Med. 2000;162:2166-71.
62. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated Creactive protein in patients with obstructive sleep apnea. Circulation. 2002;105:2462-4.
63. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev. 2003;7:35-51.
64. Redline S, Tishler PV. The genetics of sleep apnea. Sleep Med Rev. 2000;4:583-602.
65. th century. Am J Public Health. 1999;89:292-4.